Tolerance of the preruminant calf for excess manganese or zinc in milk replacer

In two experiments, calves were fed milk replacer containing 40, 200, 500, 1000, or 5000 ppm Mn or 40, 200, 500, 700, or 1000 ppm Zn in DM, from 3 to 38 d of age, to estimate the minimum toxic concentrations of Mn and Zn. Starting at 1000 ppm Mn, weight gains and feed efficiencies were decreased slightly; none of the calves fed 5000 ppm Mn survived the 5-wk experiment. Liver and bile showed the largest increases in Mn concentration. In the Zn experiment, only at 700 and 1000 ppm Zn were weight gains, DM intake, and feed efficiency reduced. Largest Zn increases were in liver, kidney, and plasma. Thus, performance of the preruminant calves was not affected adversely by 500 ppm Mn or 500 ppm Zn in milk replacer, concentrations that are markedly higher than the NRC recommendations of 40 ppm Mn and 40 ppm Zn. However, Mn and Zn concentrations increased in some tissues, and toxicities might have arisen if the trial had been continued. Evidence was not obtained indicating that the calf benefits from Mn or Zn intakes above the NRC recommendations.     

Tolerance of the calf for excess copper in milk replacer

Calves were fed milk replacer containing 10, 50, 200, 500, or 1000 ppm Cu, from 3 d to 45 d of age, to estimate the Cu concentration that would adversely affect calf performance. Weight gains and feed efficiency were similar for 10 and 50 ppm Cu but were reduced at 200 and 500 ppm Cu. All calves survived 500 ppm Cu and lower intakes, but only 4 of 7 calves survived the 1000 ppm concentration. Typical clinical symptoms of chronic Cu toxicity and hemolytic crisis were evident for the 1000 ppm calves before death. Additional 1000 ppm Zn prevented deaths for 1000 ppm Cu, but calf performance was poor. Increased Cu intakes elevated plasma ceruloplasmin and glutamic oxalacetic transaminase activity, reduced packed cell volume (hematocrit), markedly increased fecal excretion of Mo and Zn, increased Cu concentration of liver, muscle, heart, blood, and bile, and decreased Mo and Zn in liver. We found 50 ppm Cu a safe intake where milk replacer contained 48 ppm Zn and 1.1 ppm Mo. However, at lower intakes of these elements, and for longer feeding periods than 6 wk, the calf may be much more susceptible to Cu toxicity.     

Duodenal flow of digesta in preruminant calves fed clotting or nonclotting milk replacer

Four Holstein male calves each were fitted with a reentrant duodenal cannula and fed a low heat milk replacer with or without an oxalate-NaOH buffer known to prevent curd formation in the abomasum. Animals were used in a crossover design to study the effect of milk clotting on duodenal flow of DM, fat, protein, lactose, and Ca. Clotting affected the flow of DM, protein N, total N, and fat as shown by the more uniform gastric emptying of the clotting milk replacer compared with the nonclotting one. For both treatments, the flow rate of these components reached a peak 2 h after feeding. Clotting did not alter the flow rate of free amino N, lactose, and Ca. The cumulative flow of DM, lactose, and Ca was similar for the clotting and nonclotting milk replacers rising gradually during the first 4 h postfeeding and tending to plateau thereafter. The clotting milk replacer resulted in a more linear cumulative flow of fat, protein N, and total N than the nonclotting one. Proteolysis of milk protein in the abomasum was the same for the two milk replacers as indicated by the total flow of free amino N measured over 24 h. Data suggest that milk clotting modifies abomasal flow of milk constituents retained in the abomasal clot but does not alter the flow of constituents in the whey fraction.     

Effects of elevated iodine in milk replacer on calf performance

Calves were fed milk replacer containing .57, 10, 50, 100, or 200 ppm iodine (from ethylenediaminedihydroiodide) in DM, from 3 to 38 d of age, to estimate the minimum toxic concentration of iodine. Only the 200 ppm iodine intake reduced weight gains, DM intake, feed efficiency, and DM digestibility. At the 100 and 200 ppm iodine intakes, protein digestibility was reduced, and calves showed typical symptoms of iodine toxicity (nasal discharge, excessive tear and saliva formation, and coughing from tracheal congestion). Thyroid iodine increased with every elevation in iodine intake. Iodine in plasma, bile, and non-thyroid tissues started to increase at the 50 ppm intake and, except for muscle, tended to increase again at the 100 and 200 ppm intakes. Thus, the preruminant calf tolerated up to 50 ppm iodine in milk replacer DM for 5 wk postpartum. However, as iodine concentrations in plasma and nonthyroid tissues started to increase at 50 ppm iodine, an upper limit of 10 ppm would be more preferable.     

Effect of excess iron in milk replacer on calf performance

Milk replacers containing 100, 500, 1000, 2000, or 5000 ppm iron were fed to 3-d-old calves for 6 wk to estimate the lowest amount of dietary iron (added as ferrous sulfate) that would reduce calf performance. Calves tolerated all iron treatments except 5000 ppm. At this intake calves showed reduced weight gains, DM intake, feed efficiency, and digestibility of DM and protein. There were no other signs of iron toxicity and no gross abnormalities were found on postmortem examination. Percent of dietary iron in feces increased with higher dietary iron and ranged from 65 to 84%. Elevated iron intakes caused relatively small increases in iron concentration of blood plasma, bile, kidney, heart, and muscle but marked increased in spleen and liver iron, particularly in liver for the 2000 and 5000 ppm treatments. At 100 ppm iron intake, nonheme iron in liver, spleen, and kidney was composed of similar proportions of ferritin and hemosiderin, but at 5000 ppm iron intake, hemosiderin predominated in these tissues. Thus, the preruminant calf tolerated between 2000 and 5000 ppm iron in milk replacer. At toxic iron intake, calf performance and feed efficiency were reduced; there was a characteristic change to higher liver than spleen iron; and hemosiderin became the predominant iron storage compound in both tissues.     

An oxalate-sodium hydroxide buffer to study the role of milk replacer coagulation in preruminant calves

An oxalate-NaOH buffer, which prevents coagulation in the abomasum of young calves, was added to a nonclotting milk replacer based on high heat skim milk powder, to investigate effects of this buffer on digestibility and metabolism of dietary components. Twelve Holstein male calves were allotted at random in two groups of six animals each and fed the experimental milk replacers from 3 to 17 d of age. Digestibility of dry matter, protein, and fat was similar for both control and buffered milk replacers. Concentrations of plasma glucose, triglycerides, alpha-amino nitrogen, and urea were the same in animals receiving buffer treated milk replacer and control diets. The data suggests that this oxalate-NaOH buffer would be suitable to prevent milk clotting in studies dealing with the importance of coagulation in digestion and metabolism in preruminant calves.     

Soy protein concentrate and heated soy flours as protein sources in milk replacer for preruminant calves

Thirty-two male calves (8/treatment) in Trial 1 and 41 male and female calves (10 or 11/treatment) in Trial 2 were fed milk replacers containing 100% of the total protein from milk sources or 25% from milk and 75% from a soy product: soy protein concentrate; commercial heated (fully cooked) soy flour; or experimental soy flour for 6 wk. The experimental flour received moist heat sufficient to reduce trypsin inhibitor to 1 unit/mg. Calf performance improved with age on all diets. Growth, protein and dry matter digestibility, nitrogen retention, and morphology of the intestinal mucosa of calves on the all milk-protein diet were superior to those of calves on diets containing a soy product. All soy-fed groups had a humoral but no cell-mediated immune reaction to soy proteins. Soy protein concentrate and the experimental heated soy flour were superior to the commercial heated soy flour as protein sources for milk replacer.     

Effects of spray-dried whole egg and biotin in calf milk replacer

Holstein bull calves (n = 120) were fed milk replacers containing 0, 10, or 20% of the formulation (0, 22, or 44% of crude protein) as spray-dried whole egg powder in a 56-d feeding trial. Milk replacer was medicated with oxytetracycline and neomycin and was fed from d 1 to 42 of the study in a phase-fed program. All experimental milk replacers were supplemented with B vitamins, except biotin. One half of all calves were supplemented with 1 mg/kg of supplemental biotin to determine whether avidin in the egg protein product inhibited growth. Increasing spray-dried whole egg caused a linear reduction in body weight, body weight gain at 28 and 56 d of the study, calf starter intake, and feed efficiency. Calves fed milk replacers containing 0, 10, and 20% spray-dried whole egg gained an average of 486, 369, and 302 g/d, respectively, during the 56-d trial. Efficiency of feed utilization was 446, 318, and 231 g of body weight gain per kilogram of dry matter intake. Improvement in body weight and feed efficiency occurred when calves began consuming calf starter on d 29. Digestibility of protein or fat from egg may have been reduced during the trial; however, the addition of biotin to the milk replacer did not influence animal performance, suggesting that avidin in spray-dried whole egg was not responsible for impaired performance. The spray-dried whole egg product used in this study did not provide nutrients to support adequate growth of milk-fed calves.     

Viable Mycobacterium avium ssp. paratuberculosis isolated from calf milk replacer

When advising farmers on how to control Johne's disease in an infected herd, one of the main recommendations is to avoid feeding waste milk to calves and instead feed calf milk replacer (CMR). This advice is based on the assumption that CMR is free of viable Mycobacterium avium ssp. paratuberculosis (MAP) cells, an assumption that has not previously been challenged. We tested commercial CMR products (n = 83) obtained from dairy farms around the United States by the peptide-mediated magnetic separation (PMS)-phage assay, PMS followed by liquid culture (PMS-culture), and direct IS900 quantitative PCR (qPCR). Conventional microbiological analyses for total mesophilic bacterial counts, coliforms, Salmonella, coagulase-negative staphylococci, streptococci, nonhemolytic Corynebacterium spp., and Bacillus spp. were also performed to assess the overall microbiological quality of the CMR. Twenty-six (31.3%) of the 83 CMR samples showed evidence of the presence of MAP. Seventeen (20.5%) tested positive for viable MAP by the PMS-phage assay, with plaque counts ranging from 6 to 1,212 pfu/50 mL of reconstituted CMR (average 248.5 pfu/50 mL). Twelve (14.5%) CMR samples tested positive for viable MAP by PMS-culture; isolates from all 12 of these samples were subsequently confirmed by whole-genome sequencing to be different cattle strains of MAP. Seven (8.4%) CMR samples tested positive for MAP DNA by IS900 qPCR. Four CMR samples tested positive by both PMS-based tests and 5 CMR samples tested positive by IS900 qPCR plus one or other of the PMS-based tests, but only one CMR sample tested positive by all 3 MAP detection tests applied. All conventional microbiology results were within current standards for whole milk powders. A significant association existed between higher total bacterial counts and presence of viable MAP indicated by either of the PMS-based assays. This represents the first published report of the isolation of viable MAP from CMR. Our findings raise concerns about the potential ability of MAP to survive manufacture of dried milk-based products.     

Effects of fat concentration of a high-protein milk replacer on calf performance

The hypothesis was that calves fed high-fat milk replacers (MR) would have reduced starter intake, digestibility, and average daily gain (ADG). Forty-eight Holstein calves (initially 42.4 ± 1.5 kg of body weight, 2 to 3 d of age; 12 calves/treatment) were fed 0.66 kg dry matter (DM) of MR per calf daily that contained 14, 17, 20, or 23% fat. This MR had crude protein (CP) to metabolizable energy (ME) ratios ranging from 51.6 to 56.7 g of CP/Mcal of ME, which were above and below a previously determined optimum. Calves were weaned at 28 d; postweaning measurements were continued to d 56. A 20% CP starter and water were fed ad libitum all 56 d of the trial. Measurements of digestion were made using chromic oxide as a marker in the MR and starter from fecal samples collected on d 19 to 23 from 4 calves/treatment. Selected serum constituents were measured on d 21. Calves were housed individually in pens bedded with straw within a naturally ventilated barn with no added heat. The average barn temperature was 2°C. Data were analyzed as a completely randomized design using polynomial contrasts to separate differences in the means. Preweaning apparent digestibility of DM, organic matter, fat, nonfiber carbohydrates, Ca, and P and serum amylase concentration were linearly reduced as fat increased from 14 to 23%. Preweaning starter intake responded quadratically to fat, being lowest at 14 and 23% fat. A reduction in digestibility and starter intake contributed to less ADG at the higher fat concentrations in the MR. A 27% CP, 17% fat MR with 55 g of CP/Mcal of ME maximized preweaning ADG when fat concentration was varied to obtain various CP to ME ratios in the MR. Additionally, a 27% CP, 20% fat MR with 53 g of CP/Mcal of ME supported overall ADG similar to calves fed the 17% fat MR but preweaning digestion measurements and serum amylase concentrations were less than in calves fed the 17% fat MR.     

Characterization and kinetics of gastric emptying of peptides derived from milk proteins in the preruminant calf.

The gastric emptying kinetics of peptides derived from milk protein were studied in vivo in preruminant calves by collecting and characterizing the whole effluent leaving the stomach for 12 h after ingestion of crude skim milk. Peptides were isolated by reversed-phase HPLC and identified. Particular attention was paid to biologically active peptides and to peptides that could be precursors of biologically active sequences. A gastrin inhibitor, the caseinomacropeptide, was emptied from the stomach only during the first 0.5 h of digestion and rapidly hydrolysed. Precursors of immunostimulatory peptides from alpha s1- and beta-caseins were emptied throughout digestion in the gastric effluent. A precursor of beta-casomorphins (peptide 58-93 of beta-casein) was emptied from the stomach 3.5 h after the meal when it was taken on an empty stomach. From this precursor, peptides that may be resistant to hydrolysis by intestinal peptidase were obtained after in vitro hydrolysis by pancreatic enzymes. A phosphopeptide (fragment 110-142 of alpha s1-casein) was also found in digesta after a few hours of digestion. When the meal was not taken on an empty stomach, these peptides were emptied in the first digesta at a low concentration. The potential activity of these peptides is discussed. The results support the hypothesis that active sequences could still be present in the gut after the action of pancreatic enzymes.     

Digestibility measured by fecal and ileal collection in preruminant calves fed a clotting or a nonclotting milk replacer

Eight Holstein male calves, each fitted with an ileal reentrant cannula at 7 to 10 d of age, were fed a milk replacer based on low heat skim milk powder with or without an oxalate-NaOH buffer known to prevent curd formation in the abomasum. The calves were used to study the effects of milk clotting on digesta flow at the ileum and apparent digestibility measured by fecal and ileal collection. Patterns of ileal flow of total digesta, DM, N, and fat were similar for the clotting and the nonclotting milk replacers. The apparent digestibility of DM and N was higher when measured by fecal than ileal collection for both milk replacers. Digestibility of DM was higher for the clotting than for the nonclotting milk replacer when measured by ileal collection. Clotting did not affect N digestibility measured by either fecal or ileal collection. The concentration of amino acids differed generally in the ileal digesta compared with concentration in feces. In the ileal digesta, some amino acids showed lower concentrations in the clotting milk replacer fed calves compared with those fed the nonclotting milk replacer. The coefficients of digestibility of each amino acid were similar when measured by either fecal or ileal collection. Clotting had no effect on amino acid digestibility measured by both fecal and ileal collection. The data suggest that fecal collection might indicate higher digestibility as compared with ileal collection and that the absence of milk replacer clotting does not affect ileal flow and digestibility of milk replacer N and fat.     

Effects of spray-dried animal plasma in calf milk replacer on health and growth of dairy calves

Male Holstein calves (n = 120) purchased from local dairy farms were fed one of three calf milk replacers for 42 d. Experimental milk replacers were formulated to contain whey protein concentrate (WPC) as the primary protein source or WPC plus 5% spray-dried bovine plasma (SDBP) or spray-dried porcine plasma (SDPP). The SDPP was heated to remove heat-insoluble materials and provide products with similar IgG content. Calves were also fed commercial calf starter and water for ad libitum consumption. Intake, change in body weight (BW), feed efficiency, morbidity and mortality were determined. Mortality was 10, 3, and 2 in calves fed WPC, SDBP, and SDPP treatments, respectively. Morbidity, measured as the number of days that calves had diarrhea was reduced by 30% when SDBP or SDPP were fed. Calves had diarrhea for 6.9, 3.9, and 4.7 d during the 42-d study when fed commercial calf milk replacer containing WPC, SDBP, and SDPP, respectively. Fecal scores tended to be reduced and feed efficiency tended to be improved when SDBP or SDPP were fed. Mean intakes of total dry matter during the 42-d study were greater when calves were fed SDBP or SDPP and were 661, 710, and 684 g/d for calves fed WPC, SDBP, and SDPP, respectively. Mean BW gains from d0 to 42 were 231,261, and 218 g/d, respectively. Calves fed SDPP tended to have lower BW gain during the first 28 d of the study. However, difference in daily BW gain from d 1 to 28 was only 39 g/d. Inclusion of SDBP or SDPP in milk replacer reduced morbidity and mortality of milk-fed dairy calves.     

Effect of dry matter intake from whole goat milk and calf milk replacer on performance of Nubian goat kids

The dry matter in calf milk replacer was compared with dry matter in goat milk for Nubian goat kids. Kids were fed the following diets from 4 days of age for 6 wk: 1) whole goat milk (14.0% dry matter), 2) calf milk replacer (13.5% dry matter), and 3) calf milk replacer (18.0% dry matter). Body weight of kids fed whole milk and 18.0% dry matter milk replacer increased each week. Kids fed the 13.5% dry matter milk replacer increased in weight to the 3rd wk but steadily declined thereafter. Total weight gain was more for kids fed whole milk (3.89 kg) than for kids fed milk replacer diets with 13.5 or 18.0% dry matter (.79 and 3.06 kg, respectively). For the first 3 wk, average daily gain was lowest for kids fed 18.0% milk replacer diet, but highest for wk 4 to 6. These data indicate that 3-week-old goat kids can utilize large amounts of dry matter from milk replacer to sustain a rate of growth similar to that of kids fed whole milk; however, high amounts of dry matter from milk replacer are poorly utilized by kids during the first 3 wk of life.     

Erythrocyte delta-aminolevulinic acid dehydrase changes in the preruminant calf.

Sixteen preruminant, male Holstein calves were tested for erythrocyte delta-aminolevulinic acid dehydrase activity, hemoglobin and erythrocyte count in blood samples taken weekly during the first 13 wk of life. delta-Aminolevulinic acid dehydrase showed a continual increase in activity beginning at wk 3 to a maximal activity at wk 9. Hemoglobin content was decreased by wk 5 and erythrocyte count was reduced by wk 6. delta-Aminolevulinic acid dehydrase enzyme activities increased with age corresponding to changes in hemoglobin and erythrocyte count during early postnatal development of the preruminant calf.     

Influence of dietary vitamin A content on serum and liver vitamin A concentrations and health in preruminant Holstein calves fed milk replacer

Evidence has suggested that the current requirement for vitamin A tabulated by the NRC [(approximately 3800 IU of vitamin A/kg of dry matter (DM)] for dairy calves fed liquid diets is too low. The objective of this study was to assess the effects of vitamin A content in milk replacers on serum and liver vitamin A concentrations, growth, and development of clinical signs of vitamin A deficiency in calves. Male Holstein calves were separated from their dams at birth and given standardized feedings of colostrum and milk replacer for 3 d. On d 4, calves were assigned to five groups and fed milk replacer containing 2300, 6200, 9000, 18,300, or 44,000 IU of vitamin A/kg of DM. Liver biopsies and serum samples were taken on d 4, 9, 15, 21, and 28 to monitor vitamin A concentrations. Weekly physical and neurological examinations were performed to monitor the development of deficiency signs. Fecal scores, body temperature, and the presence of nasal and ocular discharge were recorded daily. Liver vitamin A concentrations in calves allotted to diets with 2300 and 6200 IU of vitamin A/kg decreased from d 4 to 28. Calves fed 9000 IU of vitamin A/kg maintained liver stores, while those fed 18,300 and 44,000 IU of vitamin A/kg had significant increases in hepatic vitamin A. A strong negative association existed between incidence of hyperthermic temperatures and vitamin A concentration in the diet; calves fed 2300 IU of vitamin A/kg had approximately three times more hyperthermic readings than did calves fed other treatments. A strong negative association also existed between fecal score and concentration of vitamin A in the diet; calves fed diets containing low vitamin A concentration had a higher incidence of high fecal scores (more watery) than did calves fed diets with higher vitamin A concentrations. Although slight differences were detected in serum retinol concentration, growth performance and incidence of ocular and nasal discharges were not different among treatment groups. Our data indicate that vitamin A concentrations of less than 9000 IU/kg of DM in milk replacers result in declining liver vitamin A stores in preruminant calves. Using the human Dietary Reference Intakes as a model for calculating the requirement, we recommend that the vitamin A requirement for preruminant calves should be increased to 11,000 IU of vitamin A/kg of DM.     

Plasma lipoproteins in neonatal, preruminant, and weaned calf

This study compared plasma lipoprotein fraction profiles and lipid composition in the calf at 3 d, 3 wk, and 12 wk (weaned). For all ages the major plasma lipoprotein fraction was high density lipoproteins (52 to 73%), followed by very high density lipoproteins (10 to 22%), low density lipoproteins (13 to 18%), and chylomicrons plus very low density lipoproteins (5 to 9%). Most plasma lipid was cholesterol esters (41 to 49%) and phosphatidylcholine (21 to 29%). Most cholesterol esters (66 to 81%) and phosphatidylcholine (68 to 80%) were in high density lipoproteins; free fatty acids (83 to 96%) and lysophosphatidylcholine (75 to 85%) in very high density lipoproteins; and triglycerides (93 to 98%) in the remaining lipoprotein fractions. Of the three ages studied, 3-d-old calves had comparatively low plasma total lipids, high density lipoproteins, cholesterol esters, phosphatidylcholine, and linoleic acid in all lipid classes; they had relatively high plasma very high density lipoproteins, triglycerides, free fatty acids, phosphatidylethanolamine, and 20:3 n-9 fatty acid (indicative of essential fatty acids deficiency). Lipoprotein classes and lipid composition were similar at wk 3 and 12. Comparison of fatty acid profiles for phosphatidylcholine with those for lysophosphatidylcholine and cholesterol esters indicated plasma lecithin-cholesterol acyltransferase was active in calves at all three ages studied.     

Fatty acid-binding protein in liver and small intestine of the preruminant calf

Cytosol obtained from differential centrifugation of homogenates from liver and small intestine mucosa was incubated with 1-[14C] oleic acid or 1-[14C] palmitic acid and filtered through Sephadex G-75. Elution profiles for both tissues showed radioactivity in two main peaks, the first corresponding to binding of fatty acid to high molecular weight proteins and the second to a protein fraction with a molecular weight of approximately 12,000 daltons. The low molecular weight fraction had high fatty acid-binding activity, which was greater for oleic than palmitic acid. The findings demonstrate the presence of fatty acid-binding protein in liver and intestinal mucosa of the preruminant calf.     

Effects of additional milk replacer feeding on calf health, growth, and selected blood metabolites in calves

The objective of the experiment was to evaluate effects of increased milk replacer feeding on growth, intake, feed efficiency, and health parameters in stressed calves. Holstein bull calves (n = 120; approximately 3 to 8 d of age) were purchased from sale barns and dairy farms and housed in fiberglass hutches. In addition, wood shavings contaminated with coronavirus were mixed with clean shavings and added to each hutch before the start of the experiment. Calves were fed either a fixed amount (454 g/d) of a 20% crude protein (CP), 20% fat milk replacer to weaning at 28 d or a variable amount (454, 681, 908, and 454 g/d on d 0 to 7, 8 to 14, 15 to 31, and 32 to 41, respectively) of a milk replacer containing 28% CP and 17% fat without or with added dietary supplement containing bovine serum. Calves were also fed commercial calf starter and water ad libitum. Plasma IgG concentration in most calves on arrival at the facility was < 10 g/L. Intake, change in body weight, feed efficiency, morbidity and mortality, and selected plasma metabolites were determined. Body weight at 28 d, 56 d, daily body weight gain, intake of milk replacer, fecal scores, days with diarrhea, and days treated with antibiotics were increased with feeding variable amount of milk replacer over the 56-d study. Starter intake from d 1 to 56 was reduced from 919 to 717 g/d in calves fed fixed and variable amounts of milk replacer, respectively. Morbidity, measured as the number of days that calves had diarrhea, was increased by 53% when a variable amount of milk replacer was fed. Calves fed variable milk replacer were treated with antibiotics for 3.1 d compared with 1.9 d for calves fed 454 g of milk replacer/d. Concentrations of plasma glucose, urea N, and insulin-like growth factor-I were increased when calves were fed variable amount of milk replacer. Dietary supplement containing bovine serum had no effect on any parameter measured. There was no effect of milk replacer feeding on concentrations of nonesterified fatty acids, total protein, or growth hormone concentrations. Plasma tumor necrosis factor-α was highest in calves with the highest plasma IgG concentrations on the day of arrival and might be related to the calf's ability to identify pathogens in the environment. Under conditions of this study, calves fed variable amount of milk replacer and exposed to immunological challenge before weaning had greater BW gain, but also increased incidence of diarrhea that required added veterinary treatments.     

Effect of energy source in calf milk replacer on performance,digestibility, and gut permeability in rearing calves

Current calf milk replacer (CMR) compositions significantly differ from whole milk in their levels of energy, protein, and minerals. Energy source is one of the major differences, as CMR contains high levels of lactose, whereas whole milk contains higher levels of fat. The aim of this study was to determine the effect of partially exchanging lactose for fat on performance, digestibility, and gut permeability in calves fed twice daily on a high feeding plane. Lactose and fat were exchanged in the CMR formulation on a weight–weight basis. The CMR were isonitrogenous but not isoenergetic. A total of 60 male Holstein-Friesian calves were assigned to 1 of 30 blocks based on serum IgG, body weight, and date of collection after birth. Within each block, calves were randomly assigned to 1 of 2 treatments: high fat and high lactose. The CMR was provided twice daily until 49 d of age, followed by a gradual weaning period of 14 d. Starter, straw, and water were available ad libitum throughout the complete study. Exchanging lactose for fat did not affect growth; intakes of starter, straw, water, crude protein, or total energy; or apparent total-tract digestibility of nutrients. Gastrointestinal permeability was assessed by measuring the recovery of lactulose and Cr in 24-h urine and the Cr concentration and lactulose:d-mannitol ratio in serum following an oral pulse dose. Urinary recoveries of Cr and lactulose were generally low in both treatments but were higher in calves fed the high-fat CMR. Accordingly, the serum lactulose:d-mannitol ratio and serum Cr concentrations were higher in calves fed the high-fat CMR. In wk 1 and during the weaning transition, calves fed the high-fat CMR had significantly fewer abnormal fecal scores. In conclusion, exchanging lactose for fat in the CMR did not affect growth performance, total feed intake, or nutrient digestibility. The high-fat CMR was associated with an increase in permeability markers but positively influenced fecal scores in calves.